Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo

Overview of attention for article published in Nanomedicine: Nanotechnology, Biology and Medicine, July 2016

Altmetric Badge

202

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#5 of 1,512)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 25 news stories from 25 outlets.

New York, Mar 22 (IANS): Researchers, including one of Indian-origin, have created a new molecule for prostate cancer that has…

Besides non-melanoma skin cancer, prostate cancer is the most common cancer among men in the U.S., suggests the Centers for…

Researchers at the University of Georgia have created a new therapeutic for prostate cancer that has shown great efficacy in…

Researchers at the University of Georgia have created a new therapeutic for prostate cancer that has shown great efficacy in…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 21 additional news stories.